Skip to main content
Cureus logoLink to Cureus
. 2024 Jan 22;16(1):e52756. doi: 10.7759/cureus.52756

Atypical Ocular Toxoplasmosis With Remote Vasculitis and Kyrieleis Plaques

Tan Teng Siew 1,2, Shahidatul-Adha Mohamad 1,, Rafidah Sudarno 2, Haslinda Md Said 2
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10882149  PMID: 38389616

Abstract

Retinal vasculitis is common in ocular toxoplasmosis (OT) and typically occurs in the same quadrant as retinochoroiditis. This is a case of atypical ocular toxoplasmosis with remote vasculitis distant from the retinochoroiditis lesion. Examination of the left fundus showed the classic posterior segment finding of “headlight in the fog” in the absence of a chorioretinal scar. Retinal vasculitis was noted in all four quadrants at the periphery far from the retinitis area. A presumptive diagnosis of acute panuveitis secondary to ocular toxoplasmosis was made despite the enzyme-linked immunosorbent assay (ELISA) for Toxoplasmosis antibody being pending. The patient was treated empirically with oral sulfamethoxazole-trimethoprim for eight weeks and received both oral and topical corticosteroids. His symptoms and ocular signs have significantly improved. This case report highlights an atypical remote localization of vasculitis with the classic appearance of retinochoroiditis and vitritis, which is highly due to toxoplasmosis. Early initiation of antibiotic therapy is recommended despite pending serology to ensure a good final visual and ocular outcome.

Keywords: ocular toxoplasmosis, atypical, kyrieleis plaques, remote vasculitis, atypical ocular toxoplasmosis

Introduction

Ocular toxoplasmosis (OT) is a common retinochoroiditis disease caused by the intracellular protozoan parasite, Toxoplasma gondii (T. gondii) [1]. T. gondii possesses the ability to infect mammals and birds, making it widely distributed across the world, affecting almost one-third of the world’s population [2,3]. About 1 in 400 people worldwide will develop OT, indicating that roughly 2% of toxoplasmosis patients will experience ocular symptoms [4].

OT is believed to arise either from the congenital or acquired route. In congenital infection, the fetus becomes infected through the placenta bloodstream, whereas, in acquired infection, the transfer of parasites usually occurs through the gastrointestinal tract. T. gondii infection in humans occurs through three primary pathways: 1) ingestion of contaminated food or water with T. gondii oocysts; 2) consumption of insufficiently cooked meat containing T. gondii tissue cysts; and 3) the passage of tachyzoites through the placenta during the initial maternal infection [2,5].

T.gondii consists of three different life forms: the oocyst, the tachyzoite, and the bradyzoite (tissue cyst). The feline or cat family is the definitive host for T. gondii, whereas humans and other mammals are intermediate hosts. Replication of oocysts occurs in cats’ intestines and they shed in the feces. Oocysts undergo sporulation and become infectious from 1-21 days in cat feces. When present in the environment, this oocyst contains sporozoites, which is a dormant form of T. gondii but is highly infectious when intermediate hosts ingest it, giving rise to tachyzoites. A tachyzoite is a rapid replication stage of the parasite once it penetrates all the nucleated cells and is disseminated throughout the tissues (brain, eye, muscle, and placenta) via blood streams in intermediate hosts. The bradyzoite remains dormant in the host’s tissues as a cyst (also known as a tissue cyst) and can become infectious once the host gets immunocompromised [2,5].

In this article, we describe a case of OT that presented with remote localization of vasculitis and Kyrieleis plaques, which is rare and atypically seen. Informed consent was taken from the patient’s parents for us to document this case report.

Case presentation

A 12-year-old Malay boy with no known medical illness presented with merely left eye redness for three days without any other symptoms. His history was unremarkable except that he had 10 pet cats at home. His best-corrected visual acuity was 6/6 on the right eye and 6/9 on the left. No relative afferent pupillary defect (RAPD) was observed. The left eye showed mild conjunctival injection, granulomatous keratic precipitates on the central corneal endothelium (Figure 1), and the presence of anterior chamber cells 4+ with an intraocular pressure of 16 mmHg.

Figure 1. Keratic precipitates on the central corneal endothelium.

Figure 1

Left fundus examinations noted a classic posterior segment finding of “headlight in the fog” focal chorioretinitis measuring 1 disc diameter (DD) size located 1 DD away from the optic disc superiorly (Figure 2). There was no chorioretinal scar adjacent to the focal chorioretinitis area. There were vitritis 1+, hyperemic swollen optic disc, mild macular striations, and multiple punctate choroiditis inferiorly.

Figure 2. Classic “headlight in the fog” chorioretinitis (green arrow) was seen superior to the hyperaemic swollen optic disc during the presentation.

Figure 2

There was no perivascular sheathing adjacent to the retinitis area, however, there was vasculitis in all four quadrants in the far peripheral retina (Figure 3). Right eye examinations were unremarkable. Optical coherence tomography (OCT) showed a left swollen optic disc but no evidence of any macular pathology. Systemic examinations were unremarkable. The clinical findings suggested that the possible differential diagnoses include ocular infections and autoimmune diseases.

Figure 3. Fundus examination at presentation showed multiple punctate choroiditis (red arrows) with retinal vasculitis (green arrows) at the far periphery of the inferior retinal.

Figure 3

Blood investigations showed a high erythrocyte sedimentation rate (ESR) of 35 mm/hour but serum anti-nuclear antibody and complements 3 and 4 were negative. There were no signs of tuberculosis (Tb) infection in the Mantoux test, sputum Tb workout, and chest X-ray. A presumptive diagnosis of acute panuveitis secondary to OT was made by a medical retina consultant. Thus, the patient was treated with oral Bactrim (sulfamethoxazole 800 mg/trimethoprim 160 mg) per day for 8 weeks and topical corticosteroid (Gutt. Dexamethasone 0.1%) 4 hourly. Oral prednisolone at 1 mg/kg/dose per day was started after 48 hours of oral Bactrim administration with a gradual tapering dose of 5 mg/week for 8 weeks. OT was later confirmed when enzyme-linked immunosorbent assay (ELISA) for serum toxoplasmosis immunoglobulin M (IgM) antibody sent earlier came back as positive. In the fourth week of treatment, left focal retinitis became more well-defined and vitritis was resolved (Figure 4B).

Figure 4. (A): Pre-treatment. (B): Following treatment, the previously seen vitritis in (A) was completely resolved while the focal chorioretinitis lesion became more well-defined.

Figure 4

The remote peripheral vasculitis and multiple inferior punctate choroiditis were resolved but the presence of Kyrieleis plaques was noted during the fourth week of follow-up (Figure 5B). At two months post-treatment, all the presented clinical signs were resolved and the left eye's visual acuity improved to 6/6.

Figure 5. (A): Pre-treatment. (B): Multiple punctate inferior choroiditis were resolved and resolving peripheral vasculitis along with Kyrieleis plaques (green arrows) were observed during the treatment (B).

Figure 5

Discussion

OT patients usually complain of floaters, blurring of vision, or vision loss. The causes of presented visual symptoms in OT is due to the recurrent posterior uveitis [5]. Typical OT is marked by the presence of both focal, white, large, full thickness necrotizing retinochoroiditis and severe vitritis manifesting as the classic sign of “headlight in the fog” [6]. It usually occurs unilaterally, adjacent to a pigmented retinochoroidal scar from a previous active toxoplasmosis infection, and is associated with retinal vasculitis [7].

Atypical OT encompasses multifocal retinochoroiditis, mild or absent vitritis, an active lesion with the absence of a chorioretinal scar (as in this case), bilateral eye involvement, papillitis, choroiditis without retinitis, hemorrhagic vasculitis, retinal artery occlusion, neovascularization, and retinal detachment [7-9]. During the acute stage of infection, retinal vasculitis in typical OT is usually seen at the local venous vasculature surrounding the retinochoroiditis area [10]. However, 36% of atypical vasculitis may also occur remotely from the active lesion, which involves four quadrants or diffuse vasculitis as in this case presentation [10,11].

Kyrieleis arteritis, also known as segmental retinal arteritis (SRA), is rare to be seen in posterior uveitis, however, it is most often reported in OT [12]. SRA indicates a severe inflammation but its presence does not worsen its prognosis [13]. White-yellowish exudates, also known as Kyrieleis plaques, are present in a beaded pattern that does not extend beyond the thickness of the artery [14]. Kyrieleis plaques were observed in this case at the remote vasculitis site during treatment as the vitritis and choroiditis had resolved.

About 45% of retinochoroiditis with retinal vasculitis were presumptively diagnosed OT [14]. Almost all serology confirmed that OT with retinochoroiditis near a pigmented scar had retinal vascular involvement ie: perivenous sheathing, periarterial sheathing, and focal periarterial plaques without leakage (Kyrieleis arteritis) [14]. Atypical OT can be challenging in its diagnosis and requires a serology antibody to T. gondii (IgM/ IgG) or polymerase chain reaction (PCR) test for aqueous or vitreous samples in detecting the T. gondii organism [15]. However, ELISA remains a widely used method for its exceptional sensitivity and specificity in detecting the T. gondii antibody and its antigenically active substances dependent on the availability of hospital laboratory facilities [16].

Classic medical therapy in acute toxoplasmosis retinochoroiditis involves a combination of anti-microbial (eg. pyrimethamine and sulphonamides) and steroids for a period of four to six weeks [17,18]. Alternative antimicrobials, such as sulfamethoxazole-trimethoprim, are popular for being well tolerated by patients and their low cost and wide availability, and are as effective as the classic therapy in reducing lesion size [18,19].

Over half of OT patients with variable periods of follow-up had a recurrence of active retinitis in a mean of 5.8 years [6]. In immunocompetent individuals, retinitis typically follows a self-limiting course and tends to resolve completely within 30 to 60 days, even without any treatment [4,18]. The severity of visual loss is dependent on the site of the chorioretinitis. OT patients may still have poor vision despite fully recovering from active OT if the chorioretinal scar involves the optic disc or macula. Complications of OT include isolated retinal tear (6%), retinal detachment (6%), retinal vascular occlusion (4.5%), epiretinal membrane (7%), macular edema (12%), subretinal neovascularization (4%), cataract (13%), and optic nerve atrophy (4%) [20].

Conclusions

This case report highlighted the atypical features of OT with the absence of a chorioretinal scar and vasculitis adjacent to the focal chorioretinitis area. The atypical remote localization of vasculitis and choroiditis at the far periphery retina in the classic appearance of “headlight in the fog” chorioretinitis is strongly due to toxoplasmosis. A Kyrieleis plaque is rarely seen, and it is important to recognize its indication (severity of the inflammation). Autoimmune and other infective causes need to be ruled out to identify the culprit of acute panuveitis. Early initiation of antibiotic therapy is warranted based on the suggestive clinical signs despite pending a confirmation serology test, to ensure a good final visual and ocular outcome. Topical and oral steroids should be administrated concomitantly with antibiotics in order to reduce the ongoing inflammations and prevent further damage to the ocular structures. Further research on this atypical OT with remote vasculitis and its clinical implications should be conducted to enhance our understanding of its pathophysiology and aid in early management.

The authors have declared that no competing interests exist.

Author Contributions

Concept and design:  Tan Teng Siew, Shahidatul-Adha Mohamad, Rafidah Sudarno, Haslinda Md Said

Acquisition, analysis, or interpretation of data:  Tan Teng Siew, Shahidatul-Adha Mohamad, Rafidah Sudarno, Haslinda Md Said

Drafting of the manuscript:  Tan Teng Siew, Shahidatul-Adha Mohamad

Critical review of the manuscript for important intellectual content:  Tan Teng Siew, Shahidatul-Adha Mohamad, Rafidah Sudarno, Haslinda Md Said

Supervision:  Tan Teng Siew, Shahidatul-Adha Mohamad

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Ocular Toxoplasmosis. Cunningham ET Jr, Belfort R Jr, Muccioli C, Arevalo JF, Zierhut M. Ocul Immunol Inflamm. 2015;23:191–193. doi: 10.3109/09273948.2015.1051360. [DOI] [PubMed] [Google Scholar]
  • 2.Pathogenesis of ocular toxoplasmosis. Smith JR, Ashander LM, Arruda SL, et al. Prog Retin Eye Res. 2021;81:100882. doi: 10.1016/j.preteyeres.2020.100882. [DOI] [PubMed] [Google Scholar]
  • 3.Epidemiology of and diagnostic strategies for toxoplasmosis. Robert-Gangneux F, Dardé ML. Clin Microbiol Rev. 2012;25:264–296. doi: 10.1128/CMR.05013-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Holland GN. Am J Ophthalmol. 2003;136:973–988. doi: 10.1016/j.ajo.2003.09.040. [DOI] [PubMed] [Google Scholar]
  • 5.Toxoplasmosis. THE LANCET. J G Montoya OL. 2004;363:1965–1973. doi: 10.1016/S0140-6736(04)16412-X. [DOI] [PubMed] [Google Scholar]
  • 6.Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study. Aleixo AL, Curi AL, Benchimol EI, Amendoeira MR. PLoS Negl Trop Dis. 2016;10:0. doi: 10.1371/journal.pntd.0004685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ocular toxoplasmosis II: clinical features, pathology and management. Butler NJ, Furtado JM, Winthrop KL, Smith JR. Clin Exp Ophthalmol. 2013;41:95–108. doi: 10.1111/j.1442-9071.2012.02838.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ruptured Retinal Arterial Macroaneurysm Secondary to Toxoplasmic Kyrieleis Arteriolitis: A Case Report. Huang N, Lee WA, Rivera S, Montezuma SR. Case Rep Ophthalmol. 2017;8:390–395. doi: 10.1159/000478720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Retinal detachment associated with ocular toxoplasmosis. Faridi A, Yeh S, Suhler EB, Smith JR, Flaxel CJ. Retina. 2015;35:358–363. doi: 10.1097/IAE.0000000000000279. [DOI] [PubMed] [Google Scholar]
  • 10.Retinal vascular involvement in acute toxoplasmic retinochoroiditis. Theodossiadis P, Kokolakis S, Ladas I, Kollia AC, Chatzoulis D, Theodossiadis G. Int Ophthalmol. 1995;19:19–24. doi: 10.1007/BF00156414. [DOI] [PubMed] [Google Scholar]
  • 11.New appraisals of Kyrieleis plaques: a multimodal imaging study. Pichi F, Veronese C, Lembo A, et al. Br J Ophthalmol. 2017;101:316–321. doi: 10.1136/bjophthalmol-2015-308246. [DOI] [PubMed] [Google Scholar]
  • 12.[Kyrieleis arteritis: report of two cases and literature review] Chazalon E, Conrath J, Ridings B, Matonti F. J Fr Ophtalmol. 2013;36:191–196. doi: 10.1016/j.jfo.2012.03.014. [DOI] [PubMed] [Google Scholar]
  • 13.[Clinical characteristics of 64 individuals carrying active posterior presumptively toxoplasmic uveitis, in Pernambuco] Lynch MI, Moraes LF, Malagueño E, Ferreira S, Cordeiro F, Oréfice F. Arq Bras Oftalmol. 2008;71:43–48. doi: 10.1590/s0004-27492008000100009. [DOI] [PubMed] [Google Scholar]
  • 14.Pattern of Retinal Vasculitis in an Egyptian Cohort. Abd El Latif E, Montasser AS, Seleet MM, et al. Ocul Immunol Inflamm. 2019;27:897–904. doi: 10.1080/09273948.2019.1588332. [DOI] [PubMed] [Google Scholar]
  • 15.Driving in Fog without Headlight: Management of a Challenging Case of Presumed Ocular Toxoplasmosis. Dutta Majumder P, Shah A, Madhuravasal Krishnan J, Rishi E, Curi AL. Ocul Immunol Inflamm. 2021;29:115–117. doi: 10.1080/09273948.2019.1657466. [DOI] [PubMed] [Google Scholar]
  • 16.Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts. Döşkaya M, Caner A, Can H, et al. PLoS One. 2014;9:0. doi: 10.1371/journal.pone.0108329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.An update on current practices in the management of ocular toxoplasmosis. Holland GN, Lewis KG. Am J Ophthalmol. 2002;134:0. doi: 10.1016/s0002-9394(02)01526-x. [DOI] [PubMed] [Google Scholar]
  • 18.Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Kalogeropoulos D, Sakkas H, Mohammed B, et al. Int Ophthalmol. 2022;42:295–321. doi: 10.1007/s10792-021-01994-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Therapy for ocular toxoplasmosis. Rothova A, Meenken C, Buitenhuis HJ, et al. Am J Ophthalmol. 1993;115:0. doi: 10.1016/s0002-9394(14)74456-3. [DOI] [PubMed] [Google Scholar]
  • 20.Ocular toxoplasmosis: Clinical features and prognosis of 154 patients. Bosch-Driessen LEH, Berendschot TTJM, Ongkosuwito J V., Rothova A. Ophthalmology. 2002;109:0. doi: 10.1016/s0161-6420(02)00990-9. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES